Search Within

ANTIPLATELET AGENTS
Results 1 - 83 of 83
Recent Advances in Antiplatelet Agents

Journal: Current Medicinal Chemistry
Volume: 9,Issue: 5
Page: 577-589
Authors: Jean-Michel Dogne, Xavier de Leval, Patricia Benoit, Jacques Delarge, Bernard Masereel and Jean-Louis David

Antiplatelet Treatment in Peripheral Arterial Disease: The Role of Novel Antiplatelet Agents

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 2
Page: 4610-4616
Authors: Chris Klonaris, Nikolaos Patelis, Anja Drebes, Sean Matheiken and Theodoros Liakakos

Oral Antiplatelet Agents and Bleeding Risk in Relation to Major Cardiovascular Surgery

Journal: Current Drug Safety
Volume: 1,Issue: 3
Page: 281-287
Authors: James McCaslin, Jonathan Smout, Patrick Kesteven and Gerard Stansby

Antiplatelet Agents and Anticoagulants: From Pharmacology to Clinical Practice

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 9
Page: 1279-1293
Authors: Maria E. Tsoumani and Alexandros D. Tselepis*

Ticagrelor and Prasugrel: Two Novel, Most-Promising Antiplatelet Agents

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 5,Issue: 3
Page: 208-211
Authors: Georgios I. Tagarakis

Antiplatelet Agents in Cardiology: A Report on Aspirin, Clopidogrel, Prasugrel, and Ticagrelor

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 1
Page: 1918-1932
Authors: Paul P. Dobesh, Sara Varnado and Meagan Doyle

Understanding the Mechanism of Platelet Thrombus Formation under Blood Flow Conditions and the Effect of New Antiplatelet Agents

Journal: Current Vascular Pharmacology
Volume: 2,Issue: 1
Page: 23-32
Authors: Shinya Goto

Historical Observations on the Discovery of Platelets, Platelet Function Testing and the First Antiplatelet Agent

Journal: Current Drug Targets
Volume: 12,Issue: 1
Page: 1792-1804
Authors: Steven R. Steinhubl

TNF-α and IL-8 in Acute Stroke and the Modulation of these Cytokines by Antiplatelet Agents

Journal: Current Neurovascular Research
Volume: 4,Issue: 1
Page: 31-37
Authors: Ali Al-Bahrani, Safa Taha, Husain Shaath and Moiz Bakhiet

Current Problems, New Opportunities and Future Directions of Antiplatelet Therapy - Increasing Role of Novel Antiplatelet Agents in Cardiovascular Diseases

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 4,Issue: 1
Page: 55-60
Authors: Marek Postula, Shazia Akram and Fozia Akram

Antiplatelet Therapy in Atherothrombotic Cardiovascular Diseases for Primary and Secondary Prevention: A Focus on Old and New Antiplatelet Agents

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 6
Page: 850-860
Authors: Burak Pamukcu, Kurt Huber and Gregory Y.H. Lip

Historical Hallmarks of Anticoagulation and Antiplatelet Agents

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 1
Page: 1857-1861
Authors: Gregory Tsoucalas, Jacques Chevallier, Marianna Karamanou, Theodoros Papaioannou, Markos Sgantzos and George Androutsos

Emerging P2Y12 Receptor Antagonists: Role in Coronary Artery Disease

Journal: Current Vascular Pharmacology
Volume: 8,Issue: 1
Page: 93-101
Authors: Carrie S. Oliphant, J. Bradford Doby, Crystal L. Blade, Kanak Das, Debabrata Mukherjee and Pranab Das



Journal: Current Pharmaceutical Design
Volume: 18,Issue: 2
Page: 3019-3033
Authors: Pier Paolo Bassareo, Vassilios Fanos, Nicoletta Iacovidou and Giuseppe Mercuro

Is There a Role for Oral Anticoagulant Therapy in Patients with Peripheral Arterial Disease?

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 4,Issue: 3
Page: 269-273
Authors: B. Cosmi and G. Palareti

Determination of the New Antiplatelet Agent Ticagrelor in Tablets by Stability-Indicating HPLC Method

Journal: Current Pharmaceutical Analysis
Volume: 10,Issue: 4
Page: 279-283
Authors: Caren Gobetti, Rubia Lazzaretti Pereira, Andreas Sebastian Loureiro Mendez and Cássia Virginia Garcia

The Role of Antiplatelet Agents in the Management of Patients Receiving Intracardiac Closure Devices

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 1
Page: 1287-1291
Authors: Andreas Franke and Harald P. Kuhl

Understanding the Mechanism and Prevention of Arterial Occlusive Thrombus Formation by Anti-Platelet Agents

Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 2,Issue: 2
Page: 149-156
Authors: S. Goto

Randomized Clinical Stroke Trials in 2006

Journal: Current Vascular Pharmacology
Volume: 6,Issue: 1
Page: 61-66
Authors: Meheroz H. Rabadi and John P. Blass

A Critical Analysis on the Impact of Antiplatelet Therapy in the Patency of Infrainguinal Bypass Grafts

Journal: Current Vascular Pharmacology
Volume: 11,Issue: 1
Page: 47-50
Authors: George S. Sfyroeras, Vassileios Saleptsis, Christos Argyriou, Georgios A. Antoniou, Frans L. Moll and Athanasios D. Giannoukas

Clopidogrel and Aspirin in Cardiovascular Medicine: Responders or Not -- Current Best Available Evidence

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 6,Issue: 4
Page: 312-322
Authors: C. E. Tourmousoglou and C. K. Rokkas

Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 9
Page: 1377-1391
Authors: Shreya Shrestha, Shannon Coy and Kimon Bekelis*

Antiplatelet Therapy in Acute Coronary Syndromes. Evidence Based Medicine

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 2
Page: 4519-4536
Authors: Evangelos Oikonomou, Georgia Vogiatzi, Georgios-Angelos Papamikroulis, Leon Naar, Gerasimos Siasos, Konstantinos Mourouzis, Theodoros Zografos, Manolis Vavuranakis, Alexis Antonopoulos and Dimitris Tousoulis

The Role of the Cytochrome P450 Polymorphisms in Clopidogrel Efficacy and Clinical Utility

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 3
Page: 427-438
Authors: D. Tousoulis, G. Siasos, M. Zaromytidou, N. Papageorgiou, E. Stefanadi, E. Oikonomou and C. Stefanadis

Triple Antiplatelet Therapy after PCI - Should or Could it be Done?

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 14,Issue: 3
Page: 235-239
Authors: Banu Sahin Yildiz, Mustafa Yildiz, Ebuzer Aydin and Ibrahim Akin

Pharmacological Inhibition of Platelet Reactivity. Clinical and Pharmacodynamic Effects

Journal: Current Vascular Pharmacology
Volume: 11,Issue: 4
Page: 431-447
Authors: Juana Valles, Antonio Moscardo, Isabel Madrid and Maria Teresa Santos

Platelet Function and Antiplatelet Therapy in Cardiovascular Disease: Implications of Genetic Polymorphisms

Journal: Current Vascular Pharmacology
Volume: 9,Issue: 4
Page: 479-489
Authors: Jayashree Shanker, Armen Yuri Gasparyan, George D. Kitas and Vijay V. Kakkar

Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 2
Page: 3788-3794
Authors: Haralampos Milionis and Patrik Michel

New Perspectives in Antiplatelet Therapy

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 3
Page: 406-427
Authors: A. Tello-Montoliu, E. Jover, J. Rivera, M. Valdes, D.J. Angiolillo and F. Marin

Perioperative Handling of Antiplatelet Drugs. A Critical Appraisal

Journal: Current Drug Targets
Volume: 14,Issue: 8
Page: 880-888
Authors: Matteo Nicola Dario Di Minno, Marco Milone, Pasquale Mastronardi, Pasquale Ambrosino, Alessandro Di Minno, Alessandro Parolari, Elena Tremoli and Domenico Prisco

What is the Role for Glycoprotein IIB/IIIA Inhibitor Use in the Catheterization Laboratory in the Current Era?

Journal: Current Vascular Pharmacology
Volume: 16,Issue: 0
Page: 1-8
Authors: Andrea Rubboli* and Giuseppe Patti

Antiplatelet Potential of Plant-Derived Glycosides as Possible Lead Compounds

Journal: Current Drug Metabolism
Volume: 19,Issue: 0
Page: 1-8
Authors: Haroon Khan*, Aini Pervaiz, Mohammad A. Kamal and Seema Patel

Treating and Preventing No Reflow in the Cardiac Catheterization Laboratory

Journal: Current Cardiology Reviews
Volume: 8,Issue: 3
Page: 209-214
Authors: Ryan Berg and Cyrus Buhari

Combined Antiplatelet Therapy: Still a Sweeping Combination in Cardiology

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11,Issue: 2
Page: 136-167
Authors: Antonis S. Manolis, Theodora A. Manolis, Prokopis Papadimitriou, Spyros Koulouris and Helen Melita

Epidemiology of Upper Gastrointestinal Damage Associated with Low-Dose Aspirin

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 3
Page: 5049-5055
Authors: Ping -I Hsu and Tzung-Jiun Tsai

Venous Thromboembolism Risk and Adequacy of Prophylaxis in High Risk Pregnancy in the Arabian Gulf

Journal: Current Vascular Pharmacology
Volume: 14,Issue: 4
Page: 368-373
Authors: Faisal Alsayegh, Waleed Al-Jassar, Salima Wani, Muna Tahlak, Awatef Albahar, Lamya Al Kharusi, Halima Al-Tamimi, Faten El-Taher, Naeema Mahmood and Ibrahim Al-Zakwani

Targeting Platelet G-Protein Coupled Receptors (GPCRs): Looking Beyond Conventional GPCR Antagonism

Journal: Current Vascular Pharmacology
Volume: 8,Issue: 2
Page: 140-154
Authors: Louisa Dowal and Robert Flaumenhaft

Recent Advances in the Discovery and Development of Direct Coagulation Factor Xa Inhibitors

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 2
Page: 2337-2347
Authors: W. R. Gould and R. J. Leadley

Antiplatelet Agents and Anticoagulants in Patients with Chronic Kidney Disease - from Pathophysiology to Clinical Practice

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 9
Page: 1366-1376
Authors: Jens Lutz* and Kerstin Jurk

Potent and Orally Bioavailable Antiplatelet Agent, PLD-301, with the Potential of Overcoming Clopidogrel Resistance

Journal: Letters in Drug Design & Discovery
Volume: 13,Issue: 3
Page: 250-254
Authors: Jingyu Chen and Michael Zhiyan Wang

Use of Antiplatelet Therapy after Percutaneous Coronary Intervention with Bare-Metal Stents and Different Types of Drug-Eluting Stents

Journal: Current Clinical Pharmacology
Volume: 8,Issue: 1
Page: 59-66
Authors: Tarunjit Singh, Linda Cuomo, Martin Cohen, Hasan A. Ahmad and Wilbert S. Aronow

Anti-Platelet Therapy for Acute Coronary Syndrome: A Review of Currently Available Agents and What the Future Holds

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 11,Issue: 2
Page: 79-86
Authors: F. A. Syed, J. H.N. Bett and D. L. Walters

The Impact of Antiplatelet Treatment on Endothelial Function

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 2
Page: 4512-4518
Authors: Emmanuel Androulakis, Karl Norrington, Constantinos Bakogiannis, Eirini Lioudaki, Gerasimos Siasos and Dimitris Tousoulis

Primary and Secondary Stroke Prevention with Antiplatelet Drugs

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 1
Page: 1293-1297
Authors: Hans-Christoph Diener

Hypercoagulability in Sickle Cell Disease and Beta-Thalassemia

Journal: Current Molecular Medicine
Volume: 8,Issue: 7
Page: 639-645
Authors: Sylvia T. Singer and Kenneth I. Ataga

Platelets and Vascular Risk: An Option for Treatment

Journal: Current Pharmaceutical Design
Volume: 13,Issue: 1
Page: 1669-1683
Authors: I. A. Jagroop, A. I. Kakafika and D. P. Mikhailidis

Aspirin Resistance: Detection, Mechanisms and Clinical Implications

Journal: Current Cardiology Reviews
Volume: 1,Issue: 3
Page: 203-211
Authors: Matthew D. Linden, A. L. Frelinger III, Karin Przyklenk, Mark I. Furman and Alan D. Michelson

Antiplatelet Treatment in Stroke: New Insights

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 2
Page: 4617-4626
Authors: Haralampos Milionis, Angelos Liontos, Kostantinos Vemmos and Konstantinos Spengos

Review of Newer Anticoagulants and Anti-platelet Agents in Acute Coronary Syndrome and Cardiovascular Diseases

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 11,Issue: 3
Page: 194-202
Authors: Sucheta Gosavi and Debabrata Mukherjee

Antiplatelet for Coronary Artery Disease in Specific Condition No Size Fits All

Journal: Current Pharmaceutical Design
Volume: 24,Issue: 4
Page: 478-495
Authors: Benny M. Setiadi, Beny Hartono, Adhitia B. Prakoso, Anggia C. Lubis, Reza M. Munandar and Muhammad Munawar*

Aspirin and Clopidogrel: A Sweeping Combination in Cardiology

Journal: Current Medicinal Chemistry - Cardiovascular & Hematological Agents
Volume: 3,Issue: 3
Page: 203-219
Authors: Antonis S. Manolis, Stylianos Tzeis, George Andrikopoulos, Spyros Koulouris and Helen Melita


Pharmacogenetics of Antithrombotic Drugs

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 1
Page: 2425-2435
Authors: D. Tassies

Microvascular Thrombosis: An Exciting but Elusive Therapeutic Target in Reperfused Acute Myocardial Infarction

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 10,Issue: 4
Page: 273-283
Authors: Jose A. Barrabes, Javier Inserte, Luis Agullo, Albert Alonso, Maribel Mirabet and David Garca-Dorado

Antiplatelet and Antithrombin Strategies in Acute Coronary Syndrome: State-Of-The-Art Review

Journal: Current Cardiology Reviews
Volume: 8,Issue: 3
Page: 239-249
Authors: Refai Showkathali and Arun Natarajan

Advances in Antiplatelet Therapy for Stroke Prevention: the New P2Y12 antagonists

Journal: Current Drug Targets
Volume: 11,Issue: 3
Page: 380-391
Authors: A. Giossi, A. Pezzini, E. Del Zotto, I. Volonghi, P. Costa, D. Ferrari and A. Padovani

Mechanisms of Platelet Activation in Acute Coronary Syndromes

Journal: Current Vascular Pharmacology
Volume: 10,Issue: 5
Page: 578-588
Authors: Dimitrios A. Stakos, Dimitrios N. Tziakas and Konstantinos Stellos

The Role of Antiplatelet Therapy in Primary Prevention. A Review

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 9
Page: 1294-1306
Authors: Lauge Ostergaard*, Emil L. Fosbol and Matthew T. Roe

Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions

Journal: Current Vascular Pharmacology
Volume: 4,Issue: 3
Page: 253-268
Authors: Eva Lonn and Jasmine Grewal

Deciphering Dual Antiplatelet Therapy in the Era of Drug-Eluting Coronary Stents

Journal: Current Drug Targets
Volume: 10,Issue: 6
Page: 519-529
Authors: Brendan Bell, Darren Walters and Christian Spaulding

New Insights into the Mechanism of Action of Aspirin in the Prevention of Colorectal Neoplasia

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 3
Page: 5116-5126
Authors: Luigia Di Francesco, Luilli Antonio López Contreras, Angela Sacco and Paola Patrignani

Secondary Stroke Prevention in Patients with Cryptogenic Stroke and Patent Foramen Ovale

Journal: Vascular Disease Prevention
Volume: 3,Issue: 2
Page: 129-141
Authors: Robert Belvis, Joan Marti-Fabregas, Dolores Cocho and Josep L. Marti-Vilalta

Intravenous Glycoprotein IIb / IIIa Antagonists: Their Benefits, Problems and Future Developments

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 1
Page: 1577-1585
Authors: Ronan Curtin

Cilostazol as a Unique Antithrombotic Agent

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 2
Page: 2289-2302
Authors: Junichi Kambayashi, Yongge Liu, Bing Sun, Yasmin Shakur, Masuhiro Yoshitake and Frank Czerwiec

Clopidogrel Generic Formulations in the Era of New Antiplatelets: A Systematic Review

Journal: Current Vascular Pharmacology
Volume: 12,Issue: 5
Page: 766-777
Authors: Maria E. Tsoumani, Kallirroi I. Kalantzi, Ioannis A. Goudevenos and Alexandros D. Tselepis

The Role of Tirofiban in the Management of Coronary Artery Disease

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 8,Issue: 2
Page: 138-146
Authors: Julian P. Winter and Craig P. Juergens

Antiplatelet Therapy and Oral Anticoagulation for Prevention of Ischemic Stroke

Journal: Current Drug Therapy
Volume: 1,Issue: 3
Page: 249-256
Authors: Christian Weimar and Hans-Christoph Diener

Silence of the Limbs: Pharmacological Symptomatic Treatment of Intermittent Claudication

Journal: Current Vascular Pharmacology
Volume: 8,Issue: 3
Page: 383-387
Authors: Tine De Backer, Robert Vander Stichele, Marc De Buyzere, Guy De Backer and Lucas Van Bortel

Factor Xa Inactivation in Acute Coronary Syndrome

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 1
Page: 1186-1190
Authors: Melanie Barantke and Hendrik Bonnemeier

Inflammation-Induced Thrombosis: Mechanisms, Disease Associations and Management

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 1
Page: 1478-1493
Authors: Kenan Aksu*, Gokhan Keser and Ayhan Donmez

The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases

Journal: Current Vascular Pharmacology
Volume: 8,Issue: 4
Page: 437-449
Authors: Armen Yuri Gasparyan, Antonios Stavropoulos-Kalinoglou, Dimitri P. Mikhailidis, Tracey E. Toms, Karen M.J. Douglas and George D. Kitas

Effects of Antiplatelet Medication on Arteriovenous Fistula Patency After Surgical Thrombectomy

Journal: Current Vascular Pharmacology
Volume: 14,Issue: 4
Page: 353-359
Authors: Chi-Hsiao Yeh, Ting-Shuo Huang, Yao-Chang Wang, Pin-Fu Huang, Tzu-Yen Huang, Tzu-Ping Chen, Shun-Ying Yin and Yu-Wei Yu

Regulators of Platelet cAMP Levels: Clinical and Therapeutic Implications

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 2
Page: 2897-2905
Authors: L. Noe, K. Peeters, B. Izzi, C. Van Geet and K. Freson

Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events: Current Strategies

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 9
Page: 1406-1423
Authors: Peter Raimondi, Elaine M. Hylek and Konstantinos N. Aronis*

Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 9
Page: 1392-1405
Authors: Dimitrios Giakoumettis, George A. Alexiou, Dimitrios A. Vrachatis, Kostas Themistoklis, Pantelis Stathis, Manolis Vavuranakis and Marios S. Themistocleous*

Platelet Function Testing: A Role for Personalised Therapy in Coronary Disease

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 9
Page: 1315-1327
Authors: Mohamed Farag and Diana A Gorog*

Hematoma Expansion Following Intracerebral Hemorrhage: Mechanisms Targeting the Coagulation Cascade and Platelet Activation

Journal: Current Drug Targets
Volume: 18,Issue: 1
Page: 1329-1344
Authors: Sherrefa R. Burchell, Jiping Tang and John H. Zhang*

Platelet Aggregation and Exogenous Factors From Animal Sources

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 4,Issue: 4
Page: 301-325
Authors: R. Manjunatha Kini

Inhibition of Platelet Adhesion to Collagen as a New Target for Antithrombotic Drugs

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 3,Issue: 2
Page: 125-140
Authors: K. Vanhoorelbeke, H. Ulrichts, A. Schoolmeester and H. Deckmyn

Medical Management of the Diabetic Patient with Coronary Artery Disease

Journal: Current Pharmaceutical Design
Volume: 14,Issue: 2
Page: 2527-2536
Authors: Kalypso Karastergiou and Juan Carlos Kaski

P2Y12 Receptor Antagonists: Which One to Choose? A Systematic Review and Meta-Analysis

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 2
Page: 4568-4576
Authors: Alexandros Briasoulis, Tesfaye Telila, Mohan Palla, Gerasimos Siasos and Dimitris Tousoulis

Antiplatelet Treatment in Ischemic Stroke Treatment

Journal: Current Topics in Medicinal Chemistry
Volume: 9,Issue: 1
Page: 1298-1316
Authors: Antonio Pinto, Domenico Di Raimondo, Antonino Tuttolomondo, Riccardo Di Sciacca, Valentina Arnao, Sergio La Placa, Glauco Milio, Salvatore Miceli and Giuseppe Licata

Current Status of Antiplatelet Therapy in Acute Coronary Syndrome

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 40-49
Authors: Debabrata Dash

Results 1 - 83 of 83